<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>TableÂ 2</label>
 <caption>
  <p>Repurposed drugs (20) and O6K inhibitor interactions with the SARS-Cov-2 3CL
   <sup>pro</sup> key amino acid residues involved in replication activity
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">S. no</th>
    <th align="left">Compound name/PubChem CID</th>
    <th align="left">H-bond residue</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left"/>
    <td align="left">O6K</td>
    <td align="left">His41, Phe140, Cys145, His163, His164, Glu166</td>
   </tr>
   <tr>
    <td align="left">1</td>
    <td align="left">7, DHF (PubChem CID:1880)</td>
    <td align="left">Ser144, His163</td>
   </tr>
   <tr>
    <td align="left">2</td>
    <td align="left">Apigenin (PubChem CID:5280443)</td>
    <td align="left">Cys145, His163</td>
   </tr>
   <tr>
    <td align="left">3</td>
    <td align="left">Luteolin (PubChem CID:5280445)</td>
    <td align="left">Thr26, His163, Glu166</td>
   </tr>
   <tr>
    <td align="left">4</td>
    <td align="left">Quercetin (PubChem CID:5280343)</td>
    <td align="left">Phe140, Leu141, Cys145</td>
   </tr>
   <tr>
    <td align="left">5</td>
    <td align="left">Amentoflavone (PubChem CID:5281600)</td>
    <td align="left">Thr26, His41, Ser46, Ser144, Cys145, Glu166</td>
   </tr>
   <tr>
    <td align="left">6</td>
    <td align="left">Bilobetin (PubChem CID:5315459)</td>
    <td align="left">Thr25, Leu141, Ser144, Cys145</td>
   </tr>
   <tr>
    <td align="left">7</td>
    <td align="left">Ginkgetin (PubChem CID:5271805)</td>
    <td align="left">Thr26, Gly143, His163</td>
   </tr>
   <tr>
    <td align="left">8</td>
    <td align="left">Chloroquine (PubChem CID:2719)</td>
    <td align="left">His41, Gly143, Cys145</td>
   </tr>
   <tr>
    <td align="left">9</td>
    <td align="left">Hydroxychloroquine (PubChem CID:3652)</td>
    <td align="left">Thr26, Asn142, Glu166</td>
   </tr>
   <tr>
    <td align="left">10</td>
    <td align="left">Artemisinin (PubChem CID:68827)</td>
    <td align="left">His41, Leu141, Asn142, Gly143, Ser144, Glu166</td>
   </tr>
   <tr>
    <td align="left">11</td>
    <td align="left">Remdesivir (PubChem CID:121304016)</td>
    <td align="left">Ser46, Ser144, Cys145, His163</td>
   </tr>
   <tr>
    <td align="left">12</td>
    <td align="left">Darunavir (PubChem CID:213039)</td>
    <td align="left">Gly143, Ser144, Cys145, His164</td>
   </tr>
   <tr>
    <td align="left">13</td>
    <td align="left">Lopinavir (PubChem CID:92727)</td>
    <td align="left">Thr26, His41, Gly143, Ser144, Cys145</td>
   </tr>
   <tr>
    <td align="left">14</td>
    <td align="left">Galidesivir (PubChem CID:10445549)</td>
    <td align="left">Phe140, Leu141, Gly143, Ser144, Cys145, His163, Glu166</td>
   </tr>
   <tr>
    <td align="left">15</td>
    <td align="left">Favipiravir (PubChem CID:492405)</td>
    <td align="left">Ser144, His163, His164, Glu166</td>
   </tr>
   <tr>
    <td align="left">16</td>
    <td align="left">Ritonavir (PubChem CID:392622)</td>
    <td align="left">Thr26, His41, Cys145</td>
   </tr>
   <tr>
    <td align="left">17</td>
    <td align="left">Umifenovir (PubChem CID:131411)</td>
    <td align="left">Thr26</td>
   </tr>
   <tr>
    <td align="left">18</td>
    <td align="left">Vitamin C (PubChem CID:54670067)</td>
    <td align="left">Asn142, Ser144, Cys145, His163, Gln166</td>
   </tr>
   <tr>
    <td align="left">19</td>
    <td align="left">Vitamin D (PubChem CID:5280795)</td>
    <td align="left">Thr24, Thr26, His41, Cys145</td>
   </tr>
   <tr>
    <td align="left">20</td>
    <td align="left">Vitamin E (PubChem CID:14985)</td>
    <td align="left">Thr25, Cys145</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
